{"DataElement":{"publicId":"3346944","version":"1","preferredName":"Laboratory Procedure Anti-Mullerian Hormone Outcome Specified Value","preferredDefinition":"the value (ng/mL) for a the medical procedure that involves testing a sample of blood for anti-mullerian hormone.","longName":"3346929v1.0:3346938v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3346929","version":"1","preferredName":"Laboratory Procedure Anti-Mullerian Hormone Outcome","preferredDefinition":"information relating to the result of a laboratory procedure that involves testing a sample of blood for anti-mullerian hormone (a protein that is encoded by the AMH gene and inhibits the development of the MÃ¼llerian ducts).","longName":"2543047v1.0:3346927v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2543047","version":"1","preferredName":"Test","preferredDefinition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2262D258-9F2F-4D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-11-16","modifiedBy":"ONEDATA","dateModified":"2006-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3346927","version":"1","preferredName":"Anti-Mullerian Hormone Receptor Type II Outcome","preferredDefinition":"Encoded by human AMHR2 Gene, the 573-amino acid 62.7 kD Anti-Mullerian Hormone Receptor Type II Ser/Thr protein kinase (TGFB Receptor Family) is a type I membrane protein.  Type II receptors bind ligand but require a type I receptor for signal transduction.  Anti-Mullerian Hormone (AMH/MIS/MIF), produced by Sertoli cells, induces regression of Mullerian ducts, which differentiate into the uterus and fallopian tubes.  Type I persistent Mullerian duct syndrome is caused by AMH gene mutation; type II syndrome is due to AMHR mutation.  (OMIM, Swiss-Prot, and NCI):The result of an action.","longName":"C21334:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anti-Muellerian Hormone Type-2 Receptor","conceptCode":"C21334","definition":"Anti-Muellerian hormone type-2 receptor (573 aa, ~63 kDa) is encoded by the human AMHR2 gene. This protein plays a role in signaling, serine/threonine phosphorylation and ligand binding.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B61EBCA6-FAF6-5FA8-E040-BB89AD436C77","latestVersionIndicator":"Yes","beginDate":"2012-01-09","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-01-09","modifiedBy":"ONEDATA","dateModified":"2012-01-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B61EBCA6-FB07-5FA8-E040-BB89AD436C77","latestVersionIndicator":"Yes","beginDate":"2012-01-09","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-01-09","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3346938","version":"1","preferredName":"Anti-Mullerian Hormone Lab Specified Value","preferredDefinition":"the value (ng/mL) for a hematological test for anti-mullerian hormone.","longName":"3346938v1.0","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"ng/ml","minLength":null,"maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":"1","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184351","version":"1","preferredName":"Value","preferredDefinition":"Value; a numerical quantity measured or assigned or computed.","longName":"Value","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-2187-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B61EBCA6-FB72-5FA8-E040-BB89AD436C77","latestVersionIndicator":"Yes","beginDate":"2012-01-09","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-01-09","modifiedBy":"SHIDED","dateModified":"2012-01-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"COG","type":"USED_BY","context":"COG"},{"name":"LAB_AMH_RSLT_VAL","type":"COG GDE Short Name","context":"COG"}],"ReferenceDocuments":[{"name":"Anti-Mullerian Hormone","type":"Preferred Question Text","description":"Anti-Mullerian Hormone","url":null,"context":"CTEP"},{"name":"COG CRF TEXT 1","type":"Alternate Question Text","description":"Anti-Mullerian Hormone (AMH):","url":null,"context":"COG"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B61FD0AA-70F3-1BCD-E040-BB89AD43630B","latestVersionIndicator":"Yes","beginDate":"2012-01-09","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-01-09","modifiedBy":"LEEW","dateModified":"2018-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}